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http://dxObjectives: Surgical closure of ventricular septal defects remains the most common pediatric cardiac surgical
procedure. No studies, however, have comprehensively analyzed risk factors and drivers of nonmortality out-
comes in the current era. The purpose of this study was to assess both baseline characteristics and outcomes
of children undergoing surgical repair of ventricular septal defects in a contemporary cohort.
Methods: This retrospective study examined a consecutive series of 369 ventricular septal defect closures at
a single institution. Because mortality is low in nearly all centers for repair of these defects, we focused on mor-
bidity and identified drivers of risk via multivariable linear regression modeling.
Results: For children younger than age 6 months undergoing ventricular septal defect closure, every extra kilo-
gram in operative weight results in a 2.3-day shorter length of stay. In an analysis of composite risk, patients
younger than age 6 months undergoing ventricular septal defect repair exhibited a 1.8-fold increase in composite
risk for each kilogram decrease in weight, whereas patients older than age 6 months experienced no significant
difference.
Conclusions: Even in the current surgical era, weight remains a significant predictor of morbidity and driver or
length of stay in young infants undergoing ventricular septal defect closure. Weight still should be considered
when discussing operative risks for children younger than age 6 months undergoing this procedure, irrespective
of the indication for operation. (J Thorac Cardiovasc Surg 2013;145:641-7)Isolated ventricular septal defects (VSDs) are the most
common congenital structural heart disease, occurring in
0.34 to 2.68 per 1000 live births.1-3 Although 80% of
patients with VSDs presenting before age 1 month will
have spontaneous closure of the defect, patients in whom
closure does not occur often require surgery.4 Surgical clo-
sure of VSDs remains the most common pediatric cardiac
surgical procedure, and there have been continued ad-
vances in surgical and medical care since Lillehei and col-
leagues5,6 performed the first successful repair in 1957, yet
surprisingly few studies have been published during the
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The Journal of Thoracic and Camortality for VSD closure,7-12 and even fewer that
comprehensively analyze current risk factors and drivers
of outcomes.4,13-15 The purpose of this study was to
assess baseline characteristics of and outcomes for
children undergoing surgical repair of simple VSDs in
a contemporary cohort, as well as to determine drivers of
these outcomes. We performed a retrospective chart
review of a consecutive surgical series (n ¼ 369) of
simple VSD closures at a single large institution. Because
mortality is low in nearly all centers for repair of VSD,
we focused on morbidity and identified drivers of risk via
multivariable linear regression modeling, with secondary
analysis focusing on length of stay.
METHODS
Patient Population
This retrospective study examined a consecutive series of 369 surgical
patients presenting to the Children’s Hospital of Philadelphia for surgical
closure of simple VSD between January 1, 2002, and December 31,
2008. Patients with a concomitant atrial septal defect, patent ductus arterio-
sus, patent foramen ovale, coarctation of the aorta, or stenotic/regurgitant
semilunar valves were included. Patients with all other complex cardiac
anomalies, including tetralogy of Fallot and double outlet right ventricle,
were excluded. Patients who had undergone previous pulmonary artery
banding were included in this study. The medical records for these patients
were retrospectively reviewed with permission from the Children’s Hospi-
tal of Philadelphia Institutional Review Board.
Of 369 patients initially identified from the surgical database, 84 were
excluded because of incomplete data sets (mostly related to perfusion
data). A combination of echocardiography reports, clinic, inpatient, and
operative notes were reviewed. Outcomes were assessed through the first
postoperative visit.rdiovascular Surgery c Volume 145, Number 3 641
Abbreviations and Acronyms
VSD ¼ ventricular septal defect
ECMO ¼ extracorporeal membrane oxygenation
TEE ¼ transesophageal echocardiogram
TTE ¼ transthoracic echocardiogram
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weight, age at operation, weight at operation, days in hospital preoperation,
days ventilated preoperation, type of VSD, size of VSD, operative indica-
tion, product of multiple gestation or in-vitro fertilization, maternal history
of diabetes, underlying genetic condition, and comorbid noncardiac medi-
cal conditions, were assessed. The sizes of preoperative and residual VSDs
were recorded from the official interpretation by staff echocardiographers.
VSD size was categorized as ‘‘small’’ (<3 mm), ‘‘moderate’’ (3-5 mm),
‘‘large’’ (6-9mm), and ‘‘very large’’ (>10mm). In the setting of multiple
VSDs, size was recorded as the sum of the total sizes. The magnitude
of semilunar valvar insufficiency was determined by review of reports
by staff echocardiographers. The indications for operation was classi-
fied into 1 of 3 mutually exclusive groups: (1) failure to thrive/con-
gestive heart failure (Category Q: ‘‘Flow’’); (2) right ventricular
obstruction, aortic insufficiency, or double chamber right ventricle
(Category O: ‘‘Obstruction’’); and (3) elevated pulmonary vascular re-
sistance (Category P: ‘‘Pulmonary’’). Although some overlap was in-
evitable, patients were separated into the diagnostic group for which
they were referred for operation by their primary cardiologists. A di-
agnosis of failure to thrive was determined by the primary cardiolo-
gist and generally based on clinical criteria, including weight less
than the fifth percentile for age or crossing 2 major percentile chan-
nels; all patients carrying the diagnosis of failure to thrive had been
prescribed either diuretics or digoxin, or both, and were receiving for-
tified feeds. A diagnosis of heart failure was made based on a combi-
nation of subjective signs and symptoms, diagnosed by the referring
cardiologist, including feeding or exercise intolerance, significant asci-
tes, or hepatomegaly. A diagnosis of obstruction was made by echo-
cardiography. A diagnosis of rising pulmonary vascular resistance was
made by either cardiac catheterization or echocardiography.
Operative factors, including crossclamp, bypass, and total operation
times, as well as surgical technique (patch closure vs primary closure)
were also assessed as drivers of outcomes, including length of stay, inci-
dence of reoperation, wound infection, postpericardiotomy syndrome,
chylous effusion, chest tube, transient or complete heart block, seizure,
rehospitalization, extracorporeal membrane oxygenation (ECMO), and
death. A composite factor of major adverse events was also assessed,
defined as death, cardiac arrest, ECMO, reoperation, stroke, or heart block
necessitating a permanent pacemaker.
Surgical Technique
All patients underwent median sternotomy. Cardiopulmonary bypass
was used for all patients. Circulatory arrest was rare. All operations were
performed by 1 of 7 surgeons at the Children’s Hospital of Philadelphia
(98% of surgeries were performed by the same 3 surgeons). Primary or Da-
cron patch closure, using either interrupted (rare) or running techniques
(most), was employed at surgeons’ discretion. Concomitant infundibular
muscle resection, valvuloplasty, vascular ring repair, atrial septal defect re-
pair, patent foramen ovale closure, patent ductus arteriosus ligation, and/or
division were performed when indicated. Modified ultrafiltration was used
in all patients. All patients received a preoperative transthoracic echocar-
diogram and either intraoperative transesophageal echocardiogram
(95.1%) or postoperative transthoracic echocardiogram (90.9%) at the
surgeon’s discretion.642 The Journal of Thoracic and Cardiovascular SurgStatistical Methods
All statistical analyses were conducted in SAS (version 9.1. SAS Insti-
tute, Inc, Cary, NC). Descriptive statistics were computed for demographic
and clinical variables using means, medians, and standard deviations for
continuous variables, and frequency tables for categorical variables.
One-way analysis of variance was used to measure the associations be-
tween indication for operation and continuous variables. Fisher’s exact
test was used to measure associations with categorical variables. Length
of stay was log10-transformated to include in correlations and regression
models. Parameter estimates were then back-transformed to correspond
to length of stay. Residuals of regression models were examined, using
log10-transformation of length of stay, and no substantial deviance from
normality was observed. Relationships between length of stay in the hospi-
tal and continuous or categorical variables were measured using Pearson
correlation coefficients and unpaired t tests, respectively. A multivariable
linear regression model of length of stay was built using variables signifi-
cantly associated with length of stay in univariable analyses, assessing fit
by adjusted R2. The results from stepwise regression were consistent
with this analysis. Associations between the composite end point and var-
ious predictors were assessed using logistic regression.
RESULTS
Descriptive Characteristics
We analyzed demographic information for 285 patients
who met inclusion criteria (Table 1). Boys and girls were
equally represented (51.6% boys, 0.7% ambiguous genita-
lia). A majority of patients were white (61.4%), followed
by black (16.5%), Hispanic (7.0%), and Asian (3.5%). A
majority of patients (71.2%) were aged<12 months, with
more than half (57.9%) younger than age 6 months. The
median age was 144 days (range, 16 days to 48.5 years)
(Appendix Table 1). Somewhat surprisingly, an underlying
genetic syndrome was present in 25.6% of patients, of
whom 49.3% had Trisomy 21 (12.6% of the total cohort).
Six percent were products of twin or triplet gestation
(vs 2.6% of all live US births), 2.5% were products of
in vitro fertilization, and 2.8% were infants of mothers
with insulin-dependent diabetes.
For most patients, the primary indication for operation
was failure to thrive/congestive heart failure (81.4%). The
next most common indication was right ventricular obstruc-
tion, aortic insufficiency, or double chamber right ventricle
(11.0%), followed by rising pulmonary vascular resistance
(7.8%). Anatomic VSD types were represented as follows:
8.4% single conoseptal (Type I), 77.9% single conoventric-
ular (Type II), 1.8% single inlet/canal type (Type III), 2.8%
single muscular (Type IV), and 9.1% multiple. Of the total
cohort, 15.1% were associated with a patent ductus arterio-
sus, 33.7% with a patent foramen ovale, and 22.8% with 1
or more atrial septal defect. One patient had associated
partial anomalous venous return (Table 2).
Hospital and operative characteristics were also exam-
ined (Appendix Table 1 and Table 2). Of the patients,
22.6% were inpatients preoperatively; 10.2% were
transferred from outside hospitals for the operation. Preop-
erative ventilation was a characteristic of 2.8% of
patients. Mean operative time was 122.9  34.9 minutesery c March 2013







<30 d 8 (2.8)
30 d-12 mo 203 (71.2)
12 mo-18 y 73 (25.6)











Trisomy 21 36 (12.6)
22q11 9 (3.2)
Trisomy 18 mosaic 3 (1.1)
Other trisomy mosaic 3 (1.1)
Other 22 (7.8)
TABLE 2. Operative characteristics (n ¼ 285)
Variable Result
Operative time (min) 122.9  34.9/119.5 (52.0-336.0)
Bypass time (min) 46.1  25.0/41.0 (16.0-221.0)
Aortic cross-clamp time (min) 27.6  13.9/25.0 (8.0-87.0)
Pre-MUF Hct (mg/dL) 30.2  3.2/30.0 (23.0-38.0)
Post-MUF Hct (mg/dL) 43.0  5.5/43.0 (30.0-63.0)
MUF time (min) 8.8  1.8/9.0 (0.0-17.0)
Aortic root diameter (cm) 1.3  0.6/1.2 (0.7-4.6)
Aortic root (z score) 2.3  10.3/1.1 (2.1-76.0)
Indication for operation*
FTT/CHF (Category Q) 232 (81.4)
RVOTO/AI/DCRV (Category O) 31 (10.9)
PHTN (Category P) 22 (7.7)
Ventricular septal defect type
Type 1 (conoseptal) 30 (10.5)
Type 2 (conoventricular) 231 (81.1)
Type 3 (inlet/canal type) 11 (3.8)





Primary closure 9 (3.2)
Type 2
Patch 208 (73.0)
Primary closure 23 (8.1)
Type 2
Patch 9 (3.2)
Primary closure 2 (0.7)
Type 4
Patch 9 (3.2)
Primary closure 2 (0.7)
Associated cardiac defects
Patent foramen ovale 96 (33.7)
Atrial septal defect 65 (22.8)





Product of multiple gestation 17 (6)
In vitro fertilization 7 (2.5)
Infant of a diabetic mother 8 (2.8)
Data are presented as mean  standard deviation/median (minimum-maximum) or
n (%). MUF Hct, Modified ultrafiltration hematocrit; FTT/CHF, failure to thrive/
congestive heart failure; RVOTO/AI/DCRV, right ventricle outflow tract obstruc-
tion/aortic insufficiency/double chambered right ventricle; PHTN, pulmonary hyper-
tension. *Indication for operation was classified in 1 of 3 mutually exclusive groups:
FTT/CHF (Category Q: ‘‘Flow’’); RVOTO/AI/DCRV (Category O: ‘‘Obstruction’’);
and elevated pulmonary vascular resistance (Category P: ‘‘Pulmonary’’).
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was 46.1  25 minutes (range, 16-221 minutes). Mean aor-
tic crossclamp time was 27.6  13.9 minutes (range 8-87
minutes). Neither bypass time nor crossclamp time changed
during the 7 years of this study, regardless of indication for
surgery or age at operation (Appendix Tables 2 and 3),
although modified ultrafiltration time decreased over time
for patients of all ages in category Q (R2, 0.093;
P < .0001). For children younger than age 6 months,
indication for operation was not correlated with time in
the operating room, time from incision, bypass time, or
crossclamp time.
All patients had either an intraoperative transesophageal
echocardiogram (TEE) (95.1%), a postoperative transtho-
racic echocardiogram (TTE) (90.9%), or both. Mean total
residual VSD on TEE was 0.6  1.0 mm and on TTE was
1.1  1.3 mm, correlating well with previously published
studies of differences between TTE and TEE analyses. Af-
ter TEE, 9 patients (3.2%) had second pump runs; 8 (2.8%)
of these to address residual or additional defects. There was
no association between residual VSD size and age, weight,
or operative indication.
Eighty percent of patients (n ¼ 228) were extubated in
the immediate postoperative period (within 1 hour of ar-
rival to the intensive care unit). Mean time of intubation
for the remaining patients was 3.5  3.8 days (range, 1-
19 days). Reintubation was required for 13 patients
(4.6%) 1 or more times postoperatively. MeanThe Journal of Thoracic and Capostoperative hospital stay was 6.5  17.5 days (range
1-269 days).
Adverse Events and Associations
We examined the prevalence of the following adverse
events: reoperation, wound infection, postpericardiotomy
syndrome, chylous effusion, chest tube, transient orrdiovascular Surgery c Volume 145, Number 3 643
TABLE 3. Event rates by operative indication*
Variable Overall (n ¼ 285) Category Q (n ¼ 232) Category P (n ¼ 22) Category O (n ¼ 31) Fisher’s exact P value
Any reoperation 14 10 (71.4) 0 (0) 4 (28.6) .094
Wound infection 4 4 (100) 0 (0) 0 (0) .999
Postpericardiotomy syndrome 3 2 (66.7) 0 (0) 1 (33.3) .466
Chylous effusion 4 2 (50.0) 2 (50.0) 0 (0) .045y
Chest tube 10 7 (70.0) 2 (20.0) 1 (10.0) .254
Heart block
Transient 10 8 (80.0) 2 (20.0) 0 (0) .197
Permanent, pacemaker placed 6 5 (83.3) 0 (0) 1 (16.7) .717
Seizure 5 5 (100.0) 0 (0) 0 (0) .999
Extracorporeal membrane
oxygenation
5 3 (60.0) 0 (0) 2 (40.0) .143
Death 5 4 (80.0) 0 (0) 1 (20.0) .650
Rehospitalization 1 1 (100) 0 (0) 0 (0) .999
Data are presented as n (%). *Indication for operation was classified in 1 of 3 mutually exclusive groups: failure to thrive/congestive heart failure (Category Q: ‘‘Flow’’); right
ventricular obstruction, aortic insufficiency, or double chamber right ventricle (Category O: ‘‘Obstruction’’); and elevated pulmonary vascular resistance (Category P: ‘‘Pulmo-
nary’’). yP>.01 to .05.
TABLE 4. Analysis of significant variables by age category
Predictor b R2 P value
6 mo
Weight at operation (kg) 5.48 0.042 .0086*
Operative time (min) 0.16 0.077 .0003y
Perfusion time (min) 0.46 0.200 <.0001y
Crossclamp time (min) 0.50 0.058 .0017*
Total ventilation time (d) 1.50 0.440 <.0001y
Genetic diagnosis (yes-no) 16.6 0.069 .0007y
>6 mo
Weight at operation (kg) — — .137
Operative time (min) 0.01 0.086 .0011*
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or death (Table 3). The most common complications were
transient or complete heart block (5.6%), followed by reop-
eration (4.9%) and pleural effusion requiring a chest tube
(3.5%). The proportions of patients with these events, con-
sidered individually or combined, were not significantly
different by indication for operation. We also examined
the composite outcome of major adverse events, defined
as reoperation, heart block requiring permanent pacer, car-
diac arrest, ECMO, or death. Major adverse events occurred
in 5.3% of patients (n ¼ 15). Four patients (1.4%) died be-
fore discharge, and 1 died at home 6 days after discharge of
an unknown reason. All 5 patients who died did so between
postoperative days 6 and 10.
To identify potential predictors of these adverse out-
comes, we analyzed their associations in a univariable anal-
ysis with measured variables. There were no significant
differences in operative time, perfusion time, or crossclamp
time for all diagnostic categories (O, P, or Q) during the
course of the 7-year study. We further divided the cohort
into those aged<6 months or aged>6 months, and small
trends emerged in univariable analyses (Table 4). We noted
decreased length of hospital stay in patients aged >6
months. Although the relative risk was small, aortic cross-
clamp time was the only significant predictor of major ad-
verse events in either group (odds ratio [OR], 1.05; 95%
confidence interval [CI], 1.02-1.08). Additionally, age>6
months was significantly associated with a decreased risk
of transient or permanent heart block (OR, 0.47; 95% CI,
0.26-0.85), whereas increased weight at operation was asso-
ciated with a decreased risk of significant postoperative
hemorrhage (OR, 0.77; 95% CI, 0.63-0.94).Perfusion time (min) 0.03 0.054 .0108z
Cross-clamp time (min) 0.04 0.031 .0534x
Total ventilation time (d) 0.67 0.190 <.0001y
Genetic diagnosis (yes-no) 1.07 0.025 .0856
*P>.001-.01. yP  .001. zP>.01-.05. xP>.05-.1.MultivariableModel andPredictors of Length of Stay
Because major adverse outcomes were infrequent, we an-
alyzed length of stay as an important clinical metric.644 The Journal of Thoracic and Cardiovascular SurgIndeed, it has recently been shown that length of stay is
a strong predictor of neurocognitive outcomes in patients
with congenital heart disease, and, certainly, is a driver of
inpatient health care costs. Thus, identifying predictors of
increased length of stay might provide information to mod-
ify practice and change outcomes. We constructed multivar-
iable predictive models of length of stay and discovered
a number of interesting observations (Table 5). For patients
aged<6 months, each 1.0 day of ventilation resulted in
a 1.3-day longer length of stay in addition to the ventilated
day, whereas every extra 1.0 kg in operative weight resulted
in a 2.3-day shorter length of stay. Finally, the presence of
a genetic condition resulted in a 9.4-day longer length of
stay. These associations in patients aged<6 months were
also strongly correlated with Category Q for operative indi-
cation (failure to thrive/congestive heart failure). In patients
aged>6 months, there were fewer associations. Each 1.0
day of ventilation resulted in a 0.6-day longer length of
stay in addition to the ventilated day. The only otherery c March 2013
TABLE 5. Multivariable model predicting length of stay
Predictor b (d) P value
Complete cohort
Age category (>6 mo or 6 mo) þ9.70 .0003*
Indication for operation — .385
6 mo
Ventilation time (d) þ1.30 <.0001y
Weight at operation (kg) 2.25 .0242z
Genetic diagnosis (yes-no) þ9.41 .0002x
>6 mo
Ventilation time (d) þ0.63 <.0001y
Operative time (min) 0.017 .0506k
*P>.001-.01. yP  .001. zP>.001-.01. xP>.01-.05. kP>.05-.1.
Anderson et al Congenital Heart Disease
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older age group was operative time, with each minute of op-
eration time resulting in a 0.17-day increase in length of
stay (P ¼ .0506), suggesting that an expeditious operation
should still be considered an important goal.
DISCUSSION
We are interested in understanding contemporary out-
comes of VSD repair in children in the current era. Specif-
ically, we wanted to catalogue how practice has changed
over a substantial period in a single large institution, and,
more importantly, we wanted to investigate the drivers of
morbidity and length of stay in this diverse group of pa-
tients. Indeed, although a vast majority of patients undergo-
ing VSD closure do well, there is considerable clinical
heterogeneity, and categorization by anatomic defect alone
may confound outcome analyses, mixing patients at high
and low risk. In addition, there have been surprisingly few
analyses of outcomes of VSD closure during the past 10
to 20 years, and even fewer that assess drivers of these out-
comes. Thus, we undertook a comprehensive analysis of
contemporary VSD closure in an effort to understand cur-
rent predictors of morbidity and length of stay.
This study examined contemporary outcomes of simple
VSD closure at a single large institution. VSD closure con-
tinues to be a relatively safe and expeditious operation, with
low morbidity and mortality. Despite advances in surgery,
perfusion, cardiology, nursing, and critical care, complica-
tions continue to plague even the simplest of procedures.
Thus, we sought to understand the drivers of morbidity as-
sociated with this procedure in a contemporary cohort.
There were few components that survived robust statistical
interrogation for morbidity and none for mortality. Some-
what surprisingly, there were few changes in practice char-
acteristics over time. For example, there was no significant
difference in total ventilation time in any diagnostic cate-
gory over time. Similarly, there was no significant change
in operative time, perfusion time, or crossclamp time for
all operative indications during the course of this 7-year
study. Not surprisingly, on the other hand, the presence ofThe Journal of Thoracic and Cagenetic conditions was strongly associated with increased
length of stay. When the cohort was further broken down
into those aged <6 months or>6 months, small trends
emerged, with a decreased length of stay in patients aged
>6 months, independent of weight. In children aged<6
months, however, weight remained a strong predictor of
outcomes and a driver of length of stay.
One important question that this study cannot completely
answer is whether the true driver of morbidity in infants un-
dergoing VSD repair is weight or age. In our cohort, weight
and age were highly correlated (P<.0001). This is notable
because clinicians regularly face the question of whether to
‘‘wait and grow’’ their patients before operation or to
‘‘hurry and operate’’ so that patients can grow. An analysis
of composite risk (ie, ECMO, death, reoperation, pace-
maker, or seizure) by age category provides some insights.
Patients aged<6 months undergoing VSD repair exhibited
a 1.8-fold increase in composite risk for each 1.0-kg de-
crease in weight (OR, 1.80; P ¼ .037). This is in contrast
to the relative stability of older patients (aged>6 months),
in whom there was no significant change in composite risk
by weight (OR, 0.998; P ¼ .952), even in patients referred
for failure to thrive. This analysis argues that, in the context
of a composite risk, in children aged>6 months, there is no
reason to delay surgery for attempted weight gain. This re-
sult correlates well with surgical bias, in which the size of
the heart does not significantly reflect the complexity of
the repair. It does not, however, answer the more frequent
debate of what to do for a 2-month old who fails to grow.
Interestingly, neither birth weight nor gestational age had
significant affects on composite risk, suggesting that post-
natal care and development is at least as important as prena-
tal care and development.
Although this study provides some valuable insights into
the drivers of risk associated with VSD closure in the cur-
rent surgical era, it has a few notable limitations. First,
this represents a single institutional experience that may
not be applicable at other sites. Second, the study design
was a retrospective chart review, reporting the operative ex-
perience of 7 surgeons, with an uneven distribution of cases
(>98% of which were performed by the same 3 surgeons).
Third, cardiac critical care, nursing, and other essential staff
who participated in care of these patients fluctuated dramat-
ically over the course of the study and were not assessed.
Fourth, other potentially important predictors of outcomes,
such as response to medical treatment before surgery, were
not available for our retrospective review, with a large num-
ber of patients (n ¼ 84) excluded for incomplete data sets
(mostly perfusion data). Fifth, our follow-up only extended
through the first postoperative clinic visit, which is both
a variable and suboptimal time frame to analyze risk for
a congenital disease. Lastly, the study does not answer sev-
eral important questions, such as when to operate on a small
infant who fails to grow. This and other questions will berdiovascular Surgery c Volume 145, Number 3 645
Congenital Heart Disease Anderson et alC
H
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these children plateau. Indeed, this plateau phenomenon is
now apparent in many anatomic congenital heart disease
subsets. We suggest that nonanatomic information, such
as can be derived from complete genomic datasets, may
some day provide the keys to understanding this variability.
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APPENDIX TABLE 2. Age distribution by reason for operation*
Age category (mo) FTT/CHF (category Q) RVOTO/AI/DCRV (category O) PHTN (category P) Total n (%)
6 150 (64.6) 1 (3.2) 13 (59.1) 164 (58.2)
>6 82 (35.3) 30 (96.8) 9 (40.9) 118 (41.8)
Median age in days
 SD/(min-max)
339  1225/(16.0-17,708.0) 1588  1316/(108.0-4824.0) 408  773/(19.0-3639.0) 483  1258/(16.0-17,708.0)
Based on analysis of variance, P<.0001 (R2, 0.095). FTT/CHF, Failure to thrive/congestive heart failure; RVOTO/AI/DCRV, right ventricle outflow tract obstruction/aortic in-
sufficiency/double chambered right ventricle; PHTN, pulmonary hypertension; SD, standard deviation. *Indication for operation was classified in 1 of 3 mutually exclusive
groups: FTT/CHF (Category Q: ‘‘Flow’’); RVOTO/AI/DCRV (Category O: ‘‘Obstruction’’); and elevated pulmonary vascular resistance (Category P: ‘‘Pulmonary’’).
APPENDIX TABLE 3. Practice variability over time, by operative indication
Variable
Overall (n ¼ 285) Category Q (n ¼ 232) Category P (n ¼ 22) Category O (n ¼ 31)
R2 P value R2 P value R2 P value R2 P value
6 mo
Total operation time 0.003 .459 0.0067 .320 0.0017 .895 — —
Perfusion time 0.011 .177 0.0089 .251 0.0032 .853 — —
Crossclamp time 0.003 .499 0.0014 .644 0.019 .651 — —
MUF time 0.075 .001* 0.072 .001* 0.20 .125 — —
Total vent time 0.001 .768 0.0054 .378 0.040 .510 — —
Total hospital time 0.007 .290 0.0051 .386 0.036 .537 — —
>6 mo
Total operation time 0.019 .133 0.015 .280 0.63 .011y 0.00061 .897
Perfusion time 0.006 .404 0.014 .305 0.51 .031y 0.028 .375
Crossclamp time 0.009 .298 0.0087 .413 0.15 .311 0.043 .269
Pre-MUF hematocrit 0.016 .178 0.070 .021y 0.31 .117 0.0059 .699
Post-MUF hematocrit 0.025 .096z 0.11 .003* 0.082 .455 0.0015 .041y
MUF time 0.020 .140 0.15 .001* 0.14 .312 0.058 .227
Total vent time 0.005 .458 0.025 .165 0.086 .443 0.077 .137
Total hospital time 0.070 .004* 0.037 .089z 0.43 .054z 0.10 .089z
Indication for operation was classified in 1 of 3 mutually exclusive groups: failure to thrive/congestive heart failure (Category Q: ‘‘Flow’’); right ventricular obstruction, aortic
insufficiency, or double chamber right ventricle (Category O: ‘‘Obstruction’’); and elevated pulmonary vascular resistance (Category P: ‘‘Pulmonary’’). MUF, Modified ultra-
filtration. *P  .01. yP>.01-.05. zP>.05-.10.
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